BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20306248)

  • 1. Lineage-specific transcription factor aberrations in AML.
    Mueller BU; Pabst T
    Cancer Treat Res; 2010; 145():109-25. PubMed ID: 20306248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
    Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the unfolded protein response in human acute myeloid leukemia.
    Schardt JA; Mueller BU; Pabst T
    Methods Enzymol; 2011; 489():227-43. PubMed ID: 21266233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
    Muntean AG; Hess JL
    Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular pathogenesis of acute myeloid leukemia.
    Steffen B; Müller-Tidow C; Schwäble J; Berdel WE; Serve H
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):195-221. PubMed ID: 16236521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.
    Senyuk V; Chakraborty S; Mikhail FM; Zhao R; Chi Y; Nucifora G
    Oncogene; 2002 May; 21(20):3232-40. PubMed ID: 12082639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel and myeloid specific role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis.
    Ageberg M; Drott K; Olofsson T; Gullberg U; Lindmark A
    Genes Chromosomes Cancer; 2008 Apr; 47(4):276-87. PubMed ID: 18181180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.
    Ichikawa M; Asai T; Saito T; Seo S; Yamazaki I; Yamagata T; Mitani K; Chiba S; Ogawa S; Kurokawa M; Hirai H
    Nat Med; 2004 Mar; 10(3):299-304. PubMed ID: 14966519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARalpha and regulates differentiation of hematopoietic cells.
    Worch J; Tickenbrock L; Schwäble J; Steffen B; Cauvet T; Mlody B; Buerger H; Koeffler HP; Berdel WE; Serve H; Müller-Tidow C
    Oncogene; 2004 Dec; 23(57):9162-72. PubMed ID: 15516979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene regulation in normal and leukaemic progenitor/stem cells.
    De Maria R; Grignani F; Testa U; Valtieri M; Ziegler BL; Peschle C
    Haematologica; 1999 Jun; 84 Suppl EHA-4():8-10. PubMed ID: 10907455
    [No Abstract]   [Full Text] [Related]  

  • 16. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
    Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
    Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factors in myeloid development: balancing differentiation with transformation.
    Rosenbauer F; Tenen DG
    Nat Rev Immunol; 2007 Feb; 7(2):105-17. PubMed ID: 17259967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S; Lenny N; Sun W; Hiebert SW
    Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The APL-associated fusion proteins.
    Minucci S; Cioce M; Maccarana M; Pelicci PG
    Haematologica; 1999 Jun; 84 Suppl EHA-4():70-1. PubMed ID: 10907473
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of Ikaros family splicing variants in human hematopoietic lineages.
    Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M
    Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.